Sign in
4

Changes in Ownership

UroGen Pharma Ltd. Filed Acc 0001209191-22-006384

Chief Medical Officer sold 1,374 shares at $7.58 ($10,415)

  • Chief Medical Officer acquired 2,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schoenberg Mark · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-01-31 Exercise or conversion : show line 1 in the form +500 22,595 D
2022-01-31 Sale : show line 2 in the form −275 $7.58 $2,085 22,320 D
2022-01-31 Exercise or conversion : show line 3 in the form +2,000 24,320 D
2022-01-31 Sale : show line 4 in the form −1,099 $7.58 $8,330 23,221 D
Open-market sales · 1,374 sh · avg $7.58 · $10,415

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2022-01-31 Exercise or conversion : show line 5 in the form Restricted Stock Units −500 500 2,000 D
2022-01-31 Grant or award : show line 6 in the form Stock Option (right to buy) +12,064 $7.72 2032-01-31 12,064 12,064 D
2022-01-31 Grant or award : show line 7 in the form Restricted Stock Units +4,000 0 4,000 D
2022-01-31 Exercise or conversion : show line 8 in the form Restricted Stock −2,000 2,000 4,000 D
Loading xslF345X03/doc4.xml…